Pharmacovigilance is a set of activities aimed at continuously evaluating all information related to the safety of medicines and ensuring a favorable benefit/risk ratio for all marketed drugs for the population. Reports of suspected adverse drug reactions are an important tool for monitoring the safety profile of medicines. For any pharmacovigilance report, quality complaint, and/or any safety-related information or information related to pregnancies occurring during the use of one of our products, or if you would like to obtain scientific, medical, or regulatory information about our products, please contact us at the following e-mail address: medicalinfo.upsaIT@upsa-ph.com
Your data will be processed in accordance with current data protection regulations, including EU Regulation 2016/679 (“General Data Protection Regulation”) and Legislative Decree 196/2003, as amended by Legislative Decree 101/2018.